LMG Life Sciences Recognizes Fenwick as Top-Ranking Firm

Euromoney has recognized Fenwick as a leading firm in the United States in its annual LMG Life Sciences directory, the definitive legal guide to the top law firms and lawyers specialized in the life sciences industry. The firm received recognition across numerous practice areas, including a Tier 1 ranking in Licensing and Collaboration and high rankings in six additional categories: Corporate, Hatch-Waxman Patent Litigation (Branded) Mergers & Acquisitions, Patent Prosecution, Patent Strategy & Management and Venture Capital.

In addition, 15 individual practitioners were recognized across numerous practice areas based on the criteria of recent significant deal and case highlights, and peer and client feedback:

• Corporate: Michael Brown, Gordon Davidson, Robert Freedman, Stephen Graham and Matthew Rossiter
• General Patent Litigation: Adam Gahtan, Melanie Mayer, Jeffrey Oelke and James Trainor
• Hatch-Waxman Patent Litigation: Adam Gahtan and James Trainor
• Licensing & Collaboration: Stefano Quintini and Effie Toshav
• Mergers & Acquisitions: Gordon Davidson, Stephen Graham, Stefano Quintini and Effie Toshav
• Patent Prosecution: Daniel Becker, Robert Hulse and Carl Morales
• Patent Strategy & Management: Daniel Becker, Robert Hulse, Carl Morales and Antonia Sequeira
• Venture Capital: Michael Brown and Matthew Rossiter

Fenwick’s full 2022 rankings are available through the LMG Life Sciences website.

Fenwick represents many of the world’s most innovative life sciences companies on their most critical corporate, IP and litigation needs. Learn more about the team on Fenwick’s life sciences industry page.